电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

SGI-1027

Inh 1020149-73-8 N-[4-[(2-Amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)benzamide
产品编号 ABIN7233289
发货至: 中国
  • 应用范围
    Inhibition (Inh)
    原理
    DNA methyltransferase inhibitor
    产品特性
    Potent and selective inhibitor of DNA methyl transferase inhibiting DNMT1, DNMT3A and DNMT3B with comparable potency (IC50=12.5, 8.0 and 7.5 956M respectively). Treatment of various cancer cell lines with SGI-1027 results in selective degradation of DNMT1 (MG-132 sensitive) with minimal effect on DNMT3A and 3B at 2.5-5 μM. Prolonged treatment of RKO cells resulted in reexpression of silenced tumor suppressor genes. Synergizes with doxorubicin at growth inhibition in neuroblastoma cell lines. Disrupts the MKK3-MYC complex in cells and inhibits MYC transcriptional activity in colon and breast cancer cells.
    纯度
    >98 %
    Chemical Name
    N-[4-[(2-Amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)benzamide
    Formula
    C27H23N7O
    Solubility
    Soluble in DMSO (35 mg/ml)
  • 限制
    仅限研究用
  • 状态
    Powder
    储存条件
    -20 °C
  • 背景
    Epigenetics,Chromatin,DNA Methyltransferase,Prions,Cancer,Bcl,Myc
    分子量
    461.5
    CAS-编号
    1020149-73-8
You are here:
客服